Gastrointestinal Over-The-Counter (OTC) Drugs Market Report 2026

Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview

• Gastrointestinal Over-The-Counter (OTC) Drugs market size has reached to $49.59 billion in 2025 • Expected to grow to $73.3 billion in 2030 at a compound annual growth rate (CAGR) of 8.1% • Growth Driver: The Increasing Prevalence Of Digestive Disorders Is Fueling The Growth Of The Market Due To Growing Digestive Health Concerns • Market Trend: Advancements In OTC Gastrointestinal Drugs For Long-Lasting Acid Relief • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Gastrointestinal Over-The-Counter (OTC) Drugs Market?

Gastrointestinal over-the-counter (OTC) drugs are medications available without a prescription to prevent or treat common digestive system problems. They offer fast and easy relief for issues such as indigestion and irregular bowel movements to effectively manage mild to moderate digestive discomfort and support overall digestive wellness safely and conveniently. The main products of gastrointestinal OTC drugs are antacids, laxatives, anti-diarrheals, anti-emetics, and others. Antacids are medications that neutralize stomach acid to relieve heartburn and indigestion. It is available in various formulations, such as tablets, capsules, liquids, and others, for several indications, including heartburn, diarrhea, constipation, gastroesophageal reflux disease (GERD), nausea, vomiting, motion sickness, and others. It is distributed through various distribution channels, such as direct tender, hospital pharmacy, retail pharmacy, online pharmacy, and others, and used by several key end-users, including hospitals, clinics, home healthcare, and others.

What Is The Gastrointestinal Over-The-Counter (OTC) Drugs Market Growth Forecast?

The gastrointestinal over-the-counter (otc) drugs market size is expected to see strong growth in the next few years. It will grow to $73.3 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to preventive digestive care adoption, e-commerce growth, clean-label otc demand, aging population, digestive health awareness. Major trends in the forecast period include rising self-medication for digestive disorders, growing demand for fast-acting otc relief, increased use of combination gastrointestinal products, expansion of online pharmacy sales, growing preference for herbal and enzyme-based products.

Global Gastrointestinal Over-The-Counter (OTC) Drugs Market Segmentation

1) By Product: Antacid, Laxatives, Anti-Diarrheal, Anti-Emetics, Other Products 2) By Formulation: Tablets, Capsules, Liquids, Other Formulations 3) By Indications: Heartburn, Diarrhoea, Constipation, Gastroesophageal Reflux Disease (GERD), Nausea, Vomiting, Motion Sickness, Other Indications 4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels 5) By End-Users: Hospitals, Clinics, Home Healthcare, Other End-Users Subsegments: 1) By Antacid: Proton Pump Inhibitors (PPIs), H2-Receptor Antagonists, Calcium Carbonate, Magnesium Hydroxide, Sodium Bicarbonate, Combination Antacids 2) By Laxatives: Bulk-Forming Laxatives, Stimulant Laxatives, Osmotic Laxatives, Stool Softeners, Lubricant Laxatives 3) By Anti-Diarrheal: Loperamide, Bismuth Subsalicylate, Probiotics, Electrolyte Solutions 4) By Anti-Emetics: Antihistamines, Bismuth Subsalicylate, Phosphorated Carbohydrate Solution, Ginger Supplements 5) By Other Products: Digestive Enzymes, Simethicone, Herbal Remedies, Activated Charcoal

What Is The Driver Of The Gastrointestinal Over-The-Counter (OTC) Drugs Market?

The increasing prevalence of digestive disorders is expected to propel the growth of the gastrointestinal OTC drugs market going forward. Digestive disorders refer to a range of conditions that affect the gastrointestinal tract, including the stomach, intestines, and associated organs. The rise in digestive disorders is mainly due to higher intake of processed, low-fiber foods, which disrupt gut health and impair digestion. Gastrointestinal OTC drugs ease digestive disorder symptoms by reducing stomach acid, regulating bowel movements, and enhancing gut health. They provide fast, convenient relief from common issues like acidity, constipation, and indigestion. For instance, in December 2023, according to the IBD Registry Ltd., a UK-based non-profit organization, the number of individuals with inflammatory bowel disease (IBD) reached over 5,300, marking an increase of more than 3,000 members compared to 2022. Therefore, the increasing prevalence of digestive disorders is driving the growth of the gastrointestinal OTC drugs market.

Key Players In The Global Gastrointestinal Over-The-Counter (OTC) Drugs Market

Major companies operating in the gastrointestinal over-the-counter (otc) drugs market are Pfizer Inc., Procter & Gamble Co., Johnson & Johnson, Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Reckitt Benckiser Group plc, Boehringer Ingelheim GmbH, Haleon plc, Sandoz AG, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Dr. Reddy's Laboratories Ltd.

Global Gastrointestinal Over-The-Counter (OTC) Drugs Market Trends and Insights

Major companies operating in the gastrointestinal OTC drugs market are focusing on developing advanced products, such as OTC proton pump inhibitors, to provide effective and long-lasting relief from acid-related disorders. Over-the-counter (OTC) proton pump inhibitors (PPIs) are a class of medications available without a prescription that reduce the production of stomach acid. They are commonly used to treat conditions such as frequent heartburn, acid reflux (GERD), and gastric ulcers. For instance, in March 2025, Eisai Co., Ltd., a Japan-based pharmaceutical company, received approval in Japan to switch its Pariet S (rabeprazole sodium 10 mg) from prescription (RX) to over-the-counter (OTC) status, making it the first OTC PPI in Japan containing the same active ingredient and dosage as the prescription product. Pariet S is indicated for stomach pain, heartburn, and bloating, offering 24-hour relief with a once-daily, easy-to-swallow tablet, and aims to address the growing need for effective gastric acid-related treatments due to lifestyle and demographic changes.

What Are Latest Mergers And Acquisitions In The Gastrointestinal Over-The-Counter (OTC) Drugs Market?

In July 2024, Cooper Consumer Health SAS, a France-based consumer healthcare company, acquired Viatris Inc.’s Over-the-Counter (OTC) business for an undisclosed amount. With this acquisition, Cooper Consumer Health aims to double its revenues and scale its presence across key European markets by adding over 200 renowned OTC brands in therapeutic areas such as feminine hygiene, antiseptics, and cholesterol reduction. Viatris Inc. is a US-based healthcare company that specializes in providing gastrointestinal over-the-counter (OTC) drugs.

Regional Insights

North America was the largest region in the gastrointestinal over-the-counter (OTC) drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Gastrointestinal Over-The-Counter (OTC) Drugs Market?

The gastrointestinal over-the-counter (OTC) drugs market consists of sales of digestive enzymes, probiotics, stool softeners, and fiber supplements. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Gastrointestinal Over-The-Counter (OTC) Drugs Market Report 2026?

The gastrointestinal over-the-counter (otc) drugs market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the gastrointestinal over-the-counter (otc) drugs industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.